About us
We are pioneering the development of pain treatments.
CBD Science is leading the development of cannabis-based treatments for cancer pain in the UK and Europe.
We are working with world-class physicians to pursue the legal availability of new pain treatments, through our Real World Evidence trials.
01.
UK & Europe
Our trials are conducted on cancer patients, in a clinical setting, using our medicinal cannabis products, starting with the UK and expanding to Europe.
02.
Real World Evidence
RWE trials are conducted on diagnosed cancer patients suffering from chronic pain. Patient level Clinical Evidence is used to assess the value of treatments based on actual health outcomes.
03.
Safer Pain Medicines
Real-world performance will enable individual management solutions which will lead to the development of safer, more suitable patient pain management programs.
Why Real-World Evidence?
Patient Solutions
Reimbursement Decisions
Regulatory Decisions
Our Team
Meet our expert team.
A diverse team with extensive experience in pharmaceuticals, regulation and finance
Shaheen Bhimani
Chairman, Chief Operating Officer
25+ years of experience with some of Canada’s largest organizations spanning many industries including Oil and Gas, Government, Distribution, Pharmaceutical, and Health Care. An extensive background operational management and technology background.
Prof. Mike Bewick
Chief Clinical Advisor
Mike is the former Deputy Medical Director at NHS England and has wide-ranging experience including planning, commissioning and providing services, leading clinical management teams on a national basis.
Rocky Dhaliwal
Chief Engineering Officer
20+ years of industry experience designing custom-built manufacturing and processing equipment for world leading manufacturers with customers in over 50 countries around the world. With a focus on ideation and innovation, Rocky uses the latest technologies to successfully take projects from inception to implementation.
Chief Executive Officer
Mike’s depth of experience in entrepreneurship, venture capital and government relations is evident by his past leadership of AVAC, Canada’s largest Agri-Tech venture capital fund and acting president of National Research Council.
Chief Commercial Officer
30+ years in the pharmaceutical industry holding senior management positions in Astra Zenca, GlaxoSmithKline and Bristol Myers before starting B2B companies specializing in Pharma Market Access, his most recent having been sold to IQVIA.
Chief Financial Officer
25+ years of public practice and company management advising corporations and their executives on financing, mergers and acquisitions, going public transaction, continuous disclosure obligations, and corporate governance.
Clinical Advisory Board.
Chief Clinical Advisor
Mike is the former Deputy Medical Director at NHS England and has wide-ranging experience including planning, commissioning and providing services, leading clinical management teams on a national basis.
Chief Operating Officer
Barney is a product & marketing entrepreneur focussing his efforts to enable access to life changing plant medicines for patients in need. Barney has worked closely with the Conscious Fund, a Venture Capital Fund focused on cannabis & psychedelics.
Clinical Advisory Board.